Metraipolis › archive › dc_917c577a22d2

Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised,… — Europe PMC PMID:41193216

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41193216
DOI
10.1136/bmjopen-2025-102124
License (as archived)
solo-consultazione
Archived
2026-11-08T19:37:51.111Z
SHA-256 of the archived text
6bd34b136a57161ce5ad2e5b941e7656577eb7ccf461e35cab4324b5a25fb462
Stable URL of this page
https://metraipolis.com/documento/dc_917c577a22d2

How to cite

Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised,… — Europe PMC PMID:41193216 — Europe PMC (en), https://europepmc.org/article/MED/41193216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_917c577a22d2 (Metraipolis archive dc_917c577a22d2, sha256 6bd34b136a57161ce5ad2e5b941e7656577eb7ccf461e35cab4324b5a25fb462)
BibTeX
@misc{dc917c577a22d2,
  title = {Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised,… — Europe PMC PMID:41193216},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41193216},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_917c577a22d2; sha256 6bd34b136a57161ce5ad2e5b941e7656577eb7ccf461e35cab4324b5a25fb462},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41193216. Agents can read the archived copy with the MCP tool read_document.